F16 is inherently cytotoxic, targeting tumor cell mitochondria to induce apoptosis and inducing tumor cell necrosis in the presence of anti-apoptotic Bcl-2 protein overexpression, with dual efficacy in killing tumor cells [42]. Here, BCL2 is linked to neoplasm.